United Kingdom · Biotechnology startup

DIOSynVax

DIOSynVax is new technology that will significantly accelerate vaccine development and achieve dramatic improvements.

Funding reportedLast round: Grant

BiotechnologyCambridge, United Kingdom

What company datasets say DIOSynVax raised

Funding, as reported

Reported in all46.5Min the source's currency
Rounds3
Last roundGrant
Last round dateMar 2022
Investors listed3

Founders and team

From DIOSynVax's own website: 6 on the team.

  • Rebecca KinsleyCEO
  • Ian McEwanCFO
  • Ralf WagnerCTO
  • Rory ShawNon-Executive Director
  • Srivatsan ParthasarthyJunior Scientist: Antigen Payload Development
  • Terry ParlettNon-Executive Director

Biotechnology in United Kingdom

Startups like it

Is this your company?

Add your raise, your deck and your story, and put DIOSynVax in front of investors. Or tell us what we have wrong.

List your startupSend a correction